Current Report Filing (8-k)
13 11월 2021 - 1:56AM
Edgar (US Regulatory)
0001598308
false
0001598308
2021-11-08
2021-11-08
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
WASHINGTON,
D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of
Report (Date of earliest event reported): November
8, 2021
GLOBAL
WHOLEHEALTH PARTNERS CORPORATION
(Exact
name of registrant as specified in its charter)
|
Nevada
|
000-56035
|
46-2316220
|
(State
or other jurisdiction
of incorporation)
|
(Commission
File Number)
|
(IRS
Employer
Identification No.)
|
|
1130
Calle Cordillera
San
Clemente, CA
|
92673
|
|
(Address
of Principal Executive Offices)
|
(Zip
Code)
|
Registrant's
telephone number, including area code (714) 392-9752
N/A
(Former name or former address, if changed since last report)
Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant
under any of the following provisions:
¨
Written communications pursuant to Rule 425 under
the Securities Act (17 CFR 230.425)
¨
Soliciting material pursuant to Rule 14a-12 under
the Exchange Act (17 CFR 240.14a-12)
¨
Pre-commencement communications pursuant to Rule
14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
¨
Pre-commencement communications pursuant to Rule
13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Indicate by check mark
whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of
this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging
growth company ☐
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period
for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Section
8 - Other Events
Item
8.01 Other Events.
Global
Wholehealth Partners Corporation (the “Company”) has established a purchasing relationship with Kisso, LLC
(“Kisso”), a supplier of Emergency Use Authorization (EUA) antigen tests for COVID-19. On November 8, 2021, the Company
purchased 10,000 boxes of EUA Approved COVID-19 Home Test Kits from Kisso for distribution. Sales
from this purchase are expected to generate revenue for the Company.
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf
by the undersigned hereunto duly authorized.
|
|
GLOBAL
WHOLEHEALTH PARTNERS CORPORATION
(Registrant)
|
|
Date:
November 12, 2021
|
By:
/s/ Charles Strongo
Charles Strongo
Chief Executive Officer
|
Global Wholehealth Partn... (CE) (USOTC:GWHP)
과거 데이터 주식 차트
부터 1월(1) 2025 으로 2월(2) 2025
Global Wholehealth Partn... (CE) (USOTC:GWHP)
과거 데이터 주식 차트
부터 2월(2) 2024 으로 2월(2) 2025
